HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
Greg Walden's Political Summary on Issue: Drugs
Track This Politician
Contact Information
No contact information available.
perm_identity
Who exactly is Walden?
Current Issue:
Drugs
Issue Category
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Data Type
Key Votes
done
Public Statements
done
Ratings/Endorsements
done
Political Courage Test
done
Apply data types
Page 3 of 21
chevron_left
1
2
3
4
5
chevron_right
01/14/2020
Hearing
:
Hearing of the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee - Walden Remarks at Oversight Hearing on Opioid Crisis
Press Release
:
Lawmakers Raise Concerns Over Increased Use of Cocaine and Methamphetamine
01/13/2020
Letter
:
Letter to Craig Landau, President and CEO of Pureau Pharma L.P. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
Letter
:
Letter to Mark Trudeau, President and CEO of Mallinckrodt Pharmaceuticals - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
Letter
:
Letter to Saeed Motahari, President and CEO of Insys Therapeutics, Inc. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
10/31/2019
Statement
:
Greg Walden Shares Concerns over Growing Dependence on Foreign Drug Manufacturing
Statement
:
Walden Statement on Legislation to Fight Fentanyl
10/30/2019
Press Release
:
DEA Utilizing SUPPORT Act to Combat Opioid Crisis
Hearing
:
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Dependence on Foreign Drug Manufacturing
10/24/2019
Press Release
:
#ForwardWithSUPPORT The Fight Against the Opioid Crisis Continues, Congress Can Do More
Page 3 of 21
chevron_left
1
2
3
4
5
chevron_right
perm_identity
Who is Walden?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward